Tibet Weixinkang Medicine Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Tibet Weixinkang Medicine Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tibet Weixinkang Medicine Co Ltd (603676) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.68 Million ≈ $2.00 Million USD) by net assets (CN¥1.53 Billion ≈ $223.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tibet Weixinkang Medicine Co Ltd (2013–2025)

Cash flow conversion efficiency of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025. This chart illustrates how Tibet Weixinkang Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tibet Weixinkang Medicine Co Ltd stock price for real-time trading data and today's change.

Tibet Weixinkang Medicine Co Ltd Cash Flow Conversion Ratio Explained

Tibet Weixinkang Medicine Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tibet Weixinkang Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Weixinkang Medicine Co Ltd ranked by their cash flow conversion efficiency. Also see Tibet Weixinkang Medicine Co Ltd (603676) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Inox Green Energy Services Limited
NSE:INOXGREEN
0.015x
Zhejiang Starry Pharm Co Ltd
SHG:603520
0.004x
Jiangsu Yike Food Group Co.Ltd
SHE:301116
0.228x
Shenzhen Prince New Materials Co Ltd
SHE:002735
0.021x
Shenzhen Soling Industrial Co Ltd
SHE:002766
0.034x
Assure Tech Hangzhou Co Ltd
SHG:688075
0.000x
Jiangsu Jiangnan High Polymer Fiber Co Ltd
SHG:600527
0.001x
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
N/A

Annual Cash Flow Conversion Efficiency for Tibet Weixinkang Medicine Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025. Review how much free cash does Tibet Weixinkang Medicine Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.48 Billion
≈ $216.04 Million
CN¥185.53 Million
≈ $27.15 Million
0.126x -53.30%
2024-12-31 CN¥1.39 Billion
≈ $202.73 Million
CN¥372.78 Million
≈ $54.55 Million
0.269x +40.51%
2023-12-31 CN¥1.34 Billion
≈ $196.13 Million
CN¥256.67 Million
≈ $37.56 Million
0.191x -5.04%
2022-12-31 CN¥1.22 Billion
≈ $178.61 Million
CN¥246.15 Million
≈ $36.02 Million
0.202x +26.10%
2021-12-31 CN¥1.07 Billion
≈ $156.17 Million
CN¥170.69 Million
≈ $24.98 Million
0.160x +17.61%
2020-12-31 CN¥983.21 Million
≈ $143.87 Million
CN¥133.70 Million
≈ $19.56 Million
0.136x +18.93%
2019-12-31 CN¥930.05 Million
≈ $136.10 Million
CN¥106.34 Million
≈ $15.56 Million
0.114x +23.41%
2018-12-31 CN¥897.64 Million
≈ $131.35 Million
CN¥83.17 Million
≈ $12.17 Million
0.093x +25.59%
2017-12-31 CN¥858.04 Million
≈ $125.56 Million
CN¥63.30 Million
≈ $9.26 Million
0.074x -67.34%
2016-12-31 CN¥459.42 Million
≈ $67.23 Million
CN¥103.79 Million
≈ $15.19 Million
0.226x -20.48%
2015-12-31 CN¥402.93 Million
≈ $58.96 Million
CN¥114.47 Million
≈ $16.75 Million
0.284x -31.35%
2014-12-31 CN¥286.28 Million
≈ $41.89 Million
CN¥118.47 Million
≈ $17.34 Million
0.414x +15.75%
2013-12-31 CN¥247.78 Million
≈ $36.26 Million
CN¥88.59 Million
≈ $12.96 Million
0.358x --

About Tibet Weixinkang Medicine Co Ltd

SHG:603676 China Drug Manufacturers - Specialty & Generic
Market Cap
$524.71 Million
CN¥3.59 Billion CNY
Market Cap Rank
#11630 Global
#3297 in China
Share Price
CN¥8.24
Change (1 day)
-1.90%
52-Week Range
CN¥8.04 - CN¥11.73
All Time High
CN¥24.05
About

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. It offers APIs; multivitamins and pediatric multivitamins for injections; concentrate of trace elements solution for infusion; compound and pediatric compound amino acid injections; iron sucrose, multiple electrolytes, potassium aspartate and magnesium… Read more